Frank Leithauser

Albert Einstein Allee 23
Ulm, BW 89081, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Iron metabolism in a mouse model of hepatocellular carcinoma.

Iron metabolism in a mouse model of hepatocellular carcinoma.

Journal: Scientific reports

Published: September 19, 2024

Modeling acute graft-versus-host disease (aGVHD) in murine bone marrow transplantation (BMT) models with MHC disparity.

Modeling acute graft-versus-host disease (aGVHD) in murine bone marrow transplantation (BMT) models with MHC disparity.

Journal: Methods in cell biology

Published: April 03, 2022

Functional IKK/NF-κB signaling in pancreatic stellate cells is essential to prevent autoimmune pancreatitis.

Functional IKK/NF-κB signaling in pancreatic stellate cells is essential to prevent autoimmune pancreatitis.

Journal: Communications biology

Published: September 08, 2021

Usefulness of BATF3 Immunohistochemistry in Diagnosing Classical Hodgkin Lymphoma.

Usefulness of BATF3 Immunohistochemistry in Diagnosing Classical Hodgkin Lymphoma.

Journal: Diagnostics (Basel, Switzerland)

Published: May 26, 2021

U-DCS: characterization of the first permanent human dendritic sarcoma cell line.

U-DCS: characterization of the first permanent human dendritic sarcoma cell line.

Journal: Scientific reports

Published: April 06, 2020

Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity.

Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity.

Journal: Clinical and experimental immunology

Published: March 30, 2020

Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancer.

Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancer.

Journal: Immunotherapy

Published: August 30, 2019

In vitro-generated alloantigen-specific Th9 cells mediate antileukemia cytotoxicity in the absence of graft-versus-host disease.

In vitro-generated alloantigen-specific Th9 cells mediate antileukemia cytotoxicity in the absence of graft-versus-host disease.

Journal: Leukemia

Published: April 29, 2019

Block of NF-kB signaling accelerates MYC-driven hepatocellular carcinogenesis and modifies the tumor phenotype towards combined hepatocellular cholangiocarcinoma.

Block of NF-kB signaling accelerates MYC-driven hepatocellular carcinogenesis and modifies the tumor phenotype towards combined hepatocellular cholangiocarcinoma.

Journal: Cancer letters

Published: March 12, 2019

Gene dosage reductions of Trf1 and/or Tin2 induce telomere DNA damage and lymphoma formation in aging mice.

Gene dosage reductions of Trf1 and/or Tin2 induce telomere DNA damage and lymphoma formation in aging mice.

Journal: Leukemia

Published: November 14, 2017

Aneuploidy-inducing gene knockdowns overlap with cancer mutations and identify Orp3 as a B-cell lymphoma suppressor.

Aneuploidy-inducing gene knockdowns overlap with cancer mutations and identify Orp3 as a B-cell lymphoma suppressor.

Journal: Oncogene

Published: May 10, 2017

CDK9 is a prognostic marker and therapeutic target in pancreatic cancer.

CDK9 is a prognostic marker and therapeutic target in pancreatic cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: February 25, 2017

Showing 1-12 of 23

Last Updated: 09/26/2026